MentionFox
Home › funding signals › Claris Biotherapeutics, Inc.
Company · SEC filings

Claris Biotherapeutics, Inc. funding history

Claris Biotherapeutics, Inc. has 6 Form D filings on record, from 2023-10-24 to 2026-08-12. Together its new offerings report $58.04M sold.

Funding historyFounders and team

What do you want to do with Claris Biotherapeutics, Inc.?

Based
HALF MOON BAY, CALIFORNIA
Industry group
Biotechnology
Filings
6
Raised (new offerings)
$58.04M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-08-12Amendment
first sale 2025-11-25
$55.74M$121.48MSEC filing
2026-08-07New offering
first sale 2025-11-25
$55.74M$121.48MSEC filing
2025-09-22New offering
first sale 2025-09-12
$2.30M$2.30MSEC filing
2025-03-07Filing——SEC filing
2024-01-08Filing——SEC filing
2023-10-24Amendment——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Claris Biotherapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/claris-biotherapeutics-inc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Claris Biotherapeutics, Inc. funding history: 6 SEC filings, $58.04M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/claris-biotherapeutics-inc